We have also shown that CTCs thus enriched from blood of patients with prostate cancer are positive for expression of PSMA, AMACR, EpCAM, and PanCK as determined by fluorescence immunocytochemistry (ICC).26 The gene discussed is FOLH1; the disease is Familial prostate cancer.